Anaplastic Malignant Neoplasm — Trials

Anaplastic Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,019 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 546
Recruiting: 290
Ph III recruiting: 18
Growth YoY: +34.5%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (324)

clinicaltrialsPublishedShowing 101–150 of 867 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07284628	Vortioxetine for Newly Diagnosed Glioblastoma(ReVoGlio)	recruiting	Phase 2	78	University of ZurichOTHER	1	Jun 29, 2026	clinicaltrials
NCT00209989	Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme	completed	Phase 2	27	Institut Claudius RegaudOTHER	1	Jun 26, 2026	clinicaltrials